15) Sexual & Reproductive Health - Contraception Flashcards
Proportion of women using oral contraception in last year
1/3
Different generations of progestogens in CHC
First generation: Norethisterone
Second generation: LNG
Third generation: Desogestrel, gestodene, norgestimate
Other: Drospirenone, dienogest, nomegestrol
Main mechanism of action of combined hormonal contraceptives
Prevention of ovulation
When to start CHC?
(1) D1-D5 of natural menstrual cycle (or D1-D5 post early pregnancy loss) without additional precautions
(2) “Quick start” at any other time (with additional precautions for 7 days) provided reasonably certain not pregnant OR UPT is negative and follow up UPT done 21 days after UPSI.
When to start CHC after EC?
Immediately after Levonelle.
5 days after EllaOne.
How to switch to CHC from another method?
- From another CHC: Start on day after last active dose.
- Desogestrel POP: Start immediately with no additional precautions
- Traditional POP: Start immediately but need additional precautions 7d
- Mirena: Start any time but use additional contraception for 7d.
- Cu-IUD: Up to D5 of menstrual cycle without precaution or any time with 7d additional precautions
Effectiveness of COCP
- Perfect use: 0.3% failure
- Typical use: 9% failure
When is a COCP classed as missed?
If not taken in 24h after it should have been
Effect of enzyme inducing drugs on CHC
Reduced effectiveness for duration of treatment and up to 28 days after
Interaction of lamotrigine and CHC
Lamotrigine may be less effective
Advice re: D&V with CHC
Follow “missed pill” advice if vomiting occurs within 3 hours of COC or severe diarrhoea occurs for 24 hours.
“Missed pill” advice for COCP, vaginal ring and patch
(1) If late restarting HFI (any number of pills, ring, patch):
- Emergency contraception if UPSI during HFI
- Take most recent missed pill and then continue pills at usual time
- Additional precautions for 7 days
- Consider 3/52 PT
(2) If miss pills during week 1:
ONE PILL ONLY/RING removed <48h/PATCH <48h:
- No EC required
- Take most recent missed pill and then continue pills at usual time
- No additional precautions required
TWO OR MORE PILLS/RING removed >48h/PATCH >48h:
- Emergency contraception if UPSI during HFI/week 1
- Take most recent missed pill and then continue pills at usual time
- Additional precautions 7 days
- Consider 3/52 UPT
(3) If miss pills during week 2/3:
ONE PILL ONLY/RING removed <48h/PATCH <48h:
- No EC required
- Take most recent missed pill and then continue pills at usual time
- No additional precautions required
TWO OR MORE PILLS/RING removed >48h/PATCH >48h:
- No EC required
- Take most recent missed pill and then continue pills at usual time
- Additional precautions 7 days
- If during week 3 - omit HFI
Precautions for accidental continued use of the same combined hormonal vaginal ring beyond 3 weeks
3-4 WEEKS:
- EC not required if ring consistently in place D21-D28
- Start HFI or insert new ring
- No additional precautions required
4-5 WEEKS:
- EC not required if ring consistently in place D21-D28
- Omit HFI and insert new ring
- Additional precautions 7 days
> 5 WEEKS:
- EC if UPSI during week 5 or later
- Omit HFI and insert new ring
- Additional precautions 7 days
- Follow up UPT
What percentage of women experience breakthrough bleeding with CHC?
10-20% per cycle which is likely to improve over first 3-4 months.
Return to fertility with CHC
99% return to spontaneous menstruation (or become pregnant) within 90 days of stopping CHC. Majority ovulate within 1 month.
1st line COCP
<30 microgram ethinylestradiol with LNG/NET
Risk of VTE with CHC
- Risk is increased 3-5 fold
- Non-users 2 per 10,000/year. CHC 5-12 per 10,000/year.
- Lower than pregnancy!
- Highest in months immediately after insertion or when restarting after break > 1 month (risk reduces over first year of use and then remains stable)
Effect of progestogen type on VTE risk
No CHC: 2 per 10,000 per year
LNG/NET/norgestimate: 5-7 per 10,000
Etongestrel/norelgestromin: 6-12 per 10,000
Drospirenon/gestodene/desogrestrel/co-cypindiol: 9-12 per 10,000
Risk of arterial thromboembolic disease with CHC
- Increased risk of MI and ischaemic stroke
- Risk higher with increased oestrogen doses but does not vary according to progestogen type
Risk of breast cancer with CHC
- Current use carries small increased risk (RR 1.2) which reduces with time after stopping (normal by 5 years)
Risk of cervical cancer with CHC
- Current use for >5 years associated with increased risk which reduces after stopping and is normal at 10 years
Advice for CHC and altitude
Avoid if spending > 1 week at altitude > 4500m
Advice for CHC and major surgery
Switch method at least 4 weeks prior to planned major surgery or expected period of limited mobility
Efficacy of male and female condoms
Male condoms: Perfect use 2% failure, typical use 18% failure
Female condoms: Perfect use 5% failure, typical use 21%
Risk of HIV transmission following exposure to known HIV positive individual for different sexual behaviours
Receptive anal intercourse 1%
Receptive vaginal intercourse 0.1%
How to use diaphragm/cap?
- Use spermicide
- Reapply spermicide before sex repeated of if it has been in situ >3h before sex
- Leave in situ 6 h following sex (max duration latex diaphragms 30h, silicone cervical cap up to 48h)
Efficacy of diaphragm/cap
Perfect use: 6% failure
Typical use: 12% failure
Recommendations re: spermicide
Use with diaphragm/cap
Condoms lubricated with N-9 not recommended (repeated and high dose use associated with increased risk of genital lesions from epithelial disruption)
Recommendations re: lubricants
Water/silicone based preparation recommended
Use of lubricant recommended for anal sex to reduce risk of condom breaking
UK-MEC 3 conditions for diaphragms/caps
- High risk of HIV
- Known HIV/AIDS
- History of TSS
- Sensitivity to latex
- Not suitable < 6 weeks postnatal
- Avoid during menstruation
Effect of BMI on combined contraception
No association between BMI and oral effectiveness although it may be reduced by bariatric surgery.
Patch may be less effective if weight >90kg.
Main mode of action of progestogen only pills
Increased volume and viscosity of cervical mucus
What percentage of people does the POP inhibit ovulation in?
60% traditional
97% desogestrel
Failure rate of POP
Typical use: 9%
Perfect use: 0.3%
(Same as COCP!)
Percentage of ectopic pregnancies if pregnancy on POP
10%
When is a traditional POP classed as a missed pill?
> 3h late (>27h since last pill)
When is the desogestrel POP classed as a missed pill?
> 12h late (>36h since last pill)
Enzyme inducing drugs and POP
Reduce efficacy
What to do if pill missed on POP?
Take missed pill + next pill. Use additional precautions 2 days. EC if UPSI since missed pill and within 48h of restarting.
How long to use additional precautions for with POP during any uncertain transitions/starting points etc?
2 days
What is the bleeding pattern reported after 12m DSG POP?
50% Amenorrhoea
40% 3-5 bleeding/spotting episodes
10% >6 bleeding/spotting episodes
When do you need additional precautions when switching from implant?
None if within 3 years since insertion
When do you need additional precautions when switching from depo?
None if within 14 weeks of last injection
UK-MEC criteria for POP
4: Current breast cancer
3: New IHD, new stroke/TIA, severe cirrhosis, hepatocellular carcinoma, past breast cancer.
Licensed duration for progestogen only implants
3 years